Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1957 1
1958 2
1960 2
1961 1
1962 2
1963 2
1964 5
1965 4
1966 1
1969 1
1971 7
1972 1
1973 5
1974 2
1975 6
1976 8
1977 10
1978 12
1979 20
1980 11
1981 17
1982 17
1983 29
1984 22
1985 38
1986 39
1987 40
1988 29
1989 39
1990 48
1991 35
1992 49
1993 45
1994 68
1995 64
1996 78
1997 84
1998 99
1999 79
2000 144
2001 127
2002 156
2003 199
2004 249
2005 328
2006 401
2007 450
2008 517
2009 588
2010 704
2011 777
2012 991
2013 1064
2014 1262
2015 1293
2016 1385
2017 1486
2018 1797
2019 2038
2020 2489
2021 2835
2022 3367
2023 3192
2024 986

Text availability

Article attribute

Article type

Publication date

Search Results

26,601 results

Results by year

Filters applied: . Clear all
Page 1
A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings.
Véniant MM, Lu SC, Atangan L, Komorowski R, Stanislaus S, Cheng Y, Wu B, Falsey JR, Hager T, Thomas VA, Ambhaikar M, Sharpsten L, Zhu Y, Kurra V, Jeswani R, Oberoi RK, Parnes JR, Honarpour N, Neutel J, Strande JL. Véniant MM, et al. Among authors: cheng y. Nat Metab. 2024 Feb;6(2):290-303. doi: 10.1038/s42255-023-00966-w. Epub 2024 Feb 5. Nat Metab. 2024. PMID: 38316982 Free PMC article. Clinical Trial.
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial.
Carbone DP, Ciuleanu TE, Schenker M, Cobo M, Bordenave S, Juan-Vidal O, Menezes J, Reinmuth N, Richardet E, Cheng Y, Mizutani H, Felip E, Zurawski B, Alexandru A, Paz-Ares L, Lu S, John T, Zhang X, Mahmood J, Hu N, De T, Santi I, Penrod JR, Yuan Y, Lee A, Reck M. Carbone DP, et al. Among authors: cheng y. J Immunother Cancer. 2024 Feb 12;12(2):e008189. doi: 10.1136/jitc-2023-008189. J Immunother Cancer. 2024. PMID: 38346853 Free PMC article. Clinical Trial.
Structure-based approaches against COVID-19.
Huang TC, Liang KH, Chang TJ, Hung KF, Wang ML, Cheng YF, Liao YT, Yang DM. Huang TC, et al. Among authors: cheng yf. J Chin Med Assoc. 2024 Feb 1;87(2):139-141. doi: 10.1097/JCMA.0000000000001043. Epub 2023 Dec 20. J Chin Med Assoc. 2024. PMID: 38305483 Review.
Magnetic modulation of lysosomes for cancer therapy.
Li Y, Lv C, Li Z, Chen C, Cheng Y. Li Y, et al. Among authors: cheng y. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Mar-Apr;16(2):e1947. doi: 10.1002/wnan.1947. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024. PMID: 38488191 Review.
Continuous ultraviolet to blue-green astrocomb.
Cheng YS, Dadi K, Mitchell T, Thompson S, Piskunov N, Wright LD, Gawith CBE, McCracken RA, Reid DT. Cheng YS, et al. Nat Commun. 2024 Feb 17;15(1):1466. doi: 10.1038/s41467-024-45924-6. Nat Commun. 2024. PMID: 38368423 Free PMC article.
Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study.
Yaghi S, Shu L, Mandel D, Leon Guerrero CR, Henninger N, Muppa J, Affan M, Ul Haq Lodhi O, Heldner MR, Antonenko K, Seiffge D, Arnold M, Salehi Omran S, Crandall R, Lester E, Lopez Mena D, Arauz A, Nehme A, Boulanger M, Touze E, Sousa JA, Sargento-Freitas J, Barata V, Castro-Chaves P, Brito MT, Khan M, Mallick D, Rothstein A, Khazaal O, Kaufmann JE, Engelter ST, Traenka C, Aguiar de Sousa D, Soares M, Rosa S, Zhou LW, Gandhi P, Field TS, Mancini S, Metanis I, Leker RR, Pan K, Dantu V, Baumgartner K, Burton T, Von Rennenberg R, Nolte CH, Choi R, MacDonald J, Bavarsad Shahripour R, Guo X, Ghannam M, Almajali M, Samaniego EA, Sanchez S, Rioux B, Zine-Eddine F, Poppe A, Fonseca AC, Baptista MF, Cruz D, Romoli M, De Marco G, Longoni M, Keser Z, Griffin K, Kuohn L, Frontera J, Amar J, Giles J, Zedde M, Pascarella R, Grisendi I, Nzwalo H, Liebeskind DS, Molaie A, Cavalier A, Kam W, Mac Grory B, Al Kasab S, Anadani M, Kicielinski K, Eltatawy A, Chervak L, Chulluncuy-Rivas R, Aziz Y, Bakradze E, Tran TL, Rodrigo-Gisbert M, Requena M, Saleh Velez F, Ortiz Gracia J, Mudassani V, de Havenon A, Vishnu VY, Yaddanapudi S, Adams L, Browngoehl A, Ranasinghe T, Dunston R, Lynch Z, Penckofer M, Sieg… See abstract for full author list ➔ Yaghi S, et al. Among authors: cheng yk. Stroke. 2024 Apr;55(4):908-918. doi: 10.1161/STROKEAHA.123.045731. Epub 2024 Feb 9. Stroke. 2024. PMID: 38335240
FPR1: A critical gatekeeper of the heart and brain.
Zhangsun Z, Dong Y, Tang J, Jin Z, Lei W, Wang C, Cheng Y, Wang B, Yang Y, Zhao H. Zhangsun Z, et al. Among authors: cheng y. Pharmacol Res. 2024 Apr;202:107125. doi: 10.1016/j.phrs.2024.107125. Epub 2024 Mar 2. Pharmacol Res. 2024. PMID: 38438091 Free article. Review.
ICU Resource Strain and Patient Outcomes.
Wang L, Wu Q, Cheng Y. Wang L, et al. Among authors: cheng y. Crit Care Med. 2024 Apr 1;52(4):e208. doi: 10.1097/CCM.0000000000006160. Epub 2024 Mar 14. Crit Care Med. 2024. PMID: 38483232 No abstract available.
26,601 results
You have reached the last available page of results. Please see the User Guide for more information.